Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland R Griffiths

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Journal of Psychopharmacology (Oxford, England)|October 8, 2015
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybinFrederick S Barrett, Matthew W Johnson, Roland R Griffiths
Archives of General Psychiatry|October 4, 2006
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effectsMatthew W Johnson, Patricia E Suess, Roland R Griffiths
Experimental and Clinical Psychopharmacology|February 18, 2010
Dose effects of triazolam and alcohol on cognitive performance in healthy volunteersBethea A Kleykamp, Roland R Griffiths, Miriam Z Mintzer
Experimental and Clinical Psychopharmacology|November 23, 2006
Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adultsMichelle R Lofwall, Roland R Griffiths, Miriam Z Mintzer
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|November 18, 2022
Ethical Issues Regarding Nonsubjective Psychedelics as Standard of CareDavid B Yaden, Brian D Earp, Roland R Griffiths
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2004
Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusersBai-Fang X Sobel, Stacey C Sigmon, Roland R Griffiths
Drug and Alcohol Dependence|June 5, 2009
Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuseLawrence P Carter, Daniel Pardi, Jane Gorsline, et al.
Journal of Caffeine Research|April 25, 2014
Evaluating Dependence Criteria for CaffeineCatherine L W Striley, Roland R Griffiths, Linda B Cottler
Drug and Alcohol Dependence|January 20, 2007
Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboonsElise M Weerts, Wolfgang Froestl, Barbara J Kaminski, et al.
Psychopharmacology|November 9, 2017
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiencesTheresa M Carbonaro, Matthew W Johnson, Ethan Hurwitz, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Journal of Psychopharmacology (Oxford, England)|October 8, 2015
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybinFrederick S Barrett, Matthew W Johnson, Roland R Griffiths
Archives of General Psychiatry|October 4, 2006
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effectsMatthew W Johnson, Patricia E Suess, Roland R Griffiths
Experimental and Clinical Psychopharmacology|February 18, 2010
Dose effects of triazolam and alcohol on cognitive performance in healthy volunteersBethea A Kleykamp, Roland R Griffiths, Miriam Z Mintzer
Experimental and Clinical Psychopharmacology|November 23, 2006
Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adultsMichelle R Lofwall, Roland R Griffiths, Miriam Z Mintzer
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|November 18, 2022
Ethical Issues Regarding Nonsubjective Psychedelics as Standard of CareDavid B Yaden, Brian D Earp, Roland R Griffiths
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 11, 2004
Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusersBai-Fang X Sobel, Stacey C Sigmon, Roland R Griffiths
Drug and Alcohol Dependence|June 5, 2009
Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuseLawrence P Carter, Daniel Pardi, Jane Gorsline, et al.
Journal of Caffeine Research|April 25, 2014
Evaluating Dependence Criteria for CaffeineCatherine L W Striley, Roland R Griffiths, Linda B Cottler
Drug and Alcohol Dependence|January 20, 2007
Attenuation of cocaine-seeking by GABA B receptor agonists baclofen and CGP44532 but not the GABA reuptake inhibitor tiagabine in baboonsElise M Weerts, Wolfgang Froestl, Barbara J Kaminski, et al.
Psychopharmacology|November 9, 2017
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiencesTheresa M Carbonaro, Matthew W Johnson, Ethan Hurwitz, et al.
Pageof 14